Literature DB >> 10936437

The remodeling of the primitive human biliary system.

C Sergi1, S Adam, P Kahl, H F Otto.   

Abstract

From 12 weeks of gestation on, a progressive remodeling of the human primitive biliary structure or ductal plate occurs. A few parts of the primitive biliary structure (peripheral tubular or ductular structures) dilate, migrate toward the center of the portal tract, and transform into mature bile ducts, while most of them gradually disappear. To the best of our knowledge, quantitative studies have been performed only to evaluate the ratio between the number of remodeled bile ducts and portal tracts during human fetal development. We studied the remodeling of the intrahepatic fetal biliary structures as well as the bile duct to portal tract ratio in the developing human liver by immunohistochemistry with monoclonal antibodies anti-bile duct type cytokeratins and using a computer-based image-analysis system. We found that the surface and the perimeter of the portal tracts, the longest axis of the migrating peripheral tubular structures, and the maturation of bile ducts follow a process continuous and active up to term, but they slow between the 20th and the 32nd week of gestation, when intraportal granulopoiesis of the liver is active.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936437     DOI: 10.1016/s0378-3782(00)00065-7

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  12 in total

Review 1.  What is the duct of Luschka?--A systematic review.

Authors:  Thomas Schnelldorfer; Michael G Sarr; David B Adams
Journal:  J Gastrointest Surg       Date:  2012-01-04       Impact factor: 3.452

Review 2.  The Role of N6-Methyladenosine in the Promotion of Hepatoblastoma: A Critical Review.

Authors:  Finn Morgan Auld; Consolato M Sergi; Roger Leng; Fan Shen
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

Review 3.  'Teratoid' Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma.

Authors:  Consolato M Sergi; Marta Rojas-Vasquez; Michelle Noga; Bryan Dicken
Journal:  Children (Basel)       Date:  2022-04-15

4.  Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.

Authors:  Shih-Chang Chuang; King-Teh Lee; Kun-Bow Tsai; Pai-Ching Sheen; Eishi Nagai; Kazuhiro Mizumoto; Masao Tanaka
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

Review 5.  Molecular pathology and genetics of congenital hepatorenal fibrocystic syndromes.

Authors:  C A Johnson; P Gissen; C Sergi
Journal:  J Med Genet       Date:  2003-05       Impact factor: 6.318

Review 6.  Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?

Authors:  Stéphanie De Rechter; Luc Breysem; Djalila Mekahli
Journal:  Front Pediatr       Date:  2017-12-20       Impact factor: 3.418

7.  Promptly reporting of critical laboratory values in pediatrics: A work in progress.

Authors:  Consolato Sergi
Journal:  World J Clin Pediatr       Date:  2018-11-12

Review 8.  Epigallocatechin-3-Gallate Toxicity in Children: A Potential and Current Toxicological Event in the Differential Diagnosis With Virus-Triggered Fulminant Hepatic Failure.

Authors:  Consolato M Sergi
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

9.  Immunohistochemical detection of polyductin and co-localization with liver progenitor cell markers during normal and abnormal development of the intrahepatic biliary system and in adult hepatobiliary carcinomas.

Authors:  Livia Dorn; Luís F Menezes; Gregor Mikuz; Herwart F Otto; Luiz F Onuchic; Consolato Sergi
Journal:  J Cell Mol Med       Date:  2008-10-06       Impact factor: 5.310

10.  Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.

Authors:  Consolato M Sergi
Journal:  Diagnostics (Basel)       Date:  2015-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.